Since the government announced its $4 billion dental care program, attention has focused on how it will be funded and whether it is affordable. But if and when it is funded and implemented, the package…
Articles on Health economics
Displaying 281 - 293 of 293 articles
Australia is facing an epidemic of chronic lifestyle-related diseases, including type 2 diabetes, heart disease, stroke and chronic lung disease. We have many treatments for these that aren’t necessarily…
A person’s health is strongly influenced by that person’s wealth. In the past, we thought this was because higher incomes meant better access to health care; we thought this was why the rich lived longer…
Last night’s budget contained an important step towards realising a National Disability Insurance Scheme (NDIS), with $1bn allocated over the next four years. Of these funds, $342.5 million will pay for…
Last week, Alzheimer’s Australia released a report that was highly critical of the way Australia’s aged care sector responds to the needs of dementia suffers and their families. It’s an issue that demands…
Recent reductions to generic drug prices should go deeper as more generic alternatives become available with the expiration…
The final sitting of federal parliament last week lacked no drama, ending with the sudden induction of Peter Slipper as speaker. It was also a mammoth week for health legislation, with the passing of the…
The social cost of alcohol to the Australian community has been overestimated, according to a University of Canterbury paper…
Australia must proceed with caution when setting up financial incentives for general practice doctors, according to a review…
The government’s plan to means test the 30% private health insurance rebate faces an uncertain future after yesterday’s scheduled parliamentary debate was delayed. Under the scheme, singles with health…
The deal’s been done and health reform is in the bag. It may not be quite as bold as originally planned by then prime minister Rudd – there’s even been a fair amount of watering down on Julia Gillard’s…
The new Victorian Health Plan 2012-22 offers a bleak prognosis: forever rising medical costs, doctors in the wrong places, hospitals overwhelmed. To make matters worse, it claims that patients can’t be…
In an attempt to contain growing health costs, the Australian Government has resisted recommendations to subsidise the pain medication Targin on the Pharmaceutical Benefits Schedule. Not only is this a…
Top contributors
-
Honorary Enterprise Professor, School of Population and Global Health, and Department of General Practice and Primary Care, The University of Melbourne
-
Program Director, Health and Aged Care, Grattan Institute
-
Professor of Health Economics, The University of Melbourne
-
Professor and Director, Macquarie University Centre for the Health Economy, Macquarie University
-
Professor of Health Economics and Director, Centre for Health Economics, Monash Business School, Monash University
-
Professor of Health Economics, Flinders University
-
Reader in Health Economics, Centre for Health Economics, University of York
-
Adjunct Associate Professor, Menzies Centre for Health Policy and Economics, University of Sydney
-
Health economist, University of Sydney
-
Professor of Health Economics and Director, Centre for Health Economics Research and Evaluation, University of Technology Sydney
-
Professor, Public Service Research, UNSW Sydney
-
Senior Research Fellow, Melbourne Institute of Applied Economic and Social Research, The University of Melbourne
-
Jim Gillespie is a Friend of The Conversation.
Associate Professor in Health Policy, Leeder Centre for Health Policy, Economics and Data & Sydney School of Public Health, University of Sydney
-
Senior Policy Adviser, National Rural Health Alliance; Adjunct Lecturer, University of Sydney
-
Associate Professor, Centre for Health Economics, Monash University